Market Tracker

02/28 9:14am ET

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

0.69
Delayed Data
As of Feb 27
 -0.005 / -0.72%
Today’s Change
0.60
Today|||52-Week Range
3.27
-3.46%
Year-to-Date
No recent news for Rxi Pharmaceuticals Corp.

Today’s Trading

Previous close0.70
Today’s open0.69
Day’s range0.68 - 0.70
Volume210,988
Average volume (3 months)740,902
Market cap$4.6M
Dividend yield--
Data as of 02/27/2017

Growth & Valuation

Earnings growth (last year)+73.42%
Earnings growth (this year)+44.29%
Earnings growth (next 5 years)--
Revenue growth (last year)-52.11%
P/E ratioNM
Price/Sales558.44
Price/Book0.51

Competitors

 Today’s
change
Today’s
% change
CLSNCelsion Corp+0.02+11.14%
XTNTXtant Medical Holdin...+0.07+17.47%
RGBPRegen BioPharma Inc+0.00+3.57%
IGCIndia Globalization ...-0.00-1.08%
Data as of 02/27/2017

Financials

Next reporting dateApril 5, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$34.0K
Annual profit (last year)-$10.2M
Net profit margin-30,067.65%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Marlborough, Massachusetts

Forecasts